Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norgestrel 75 mcg Delayed and Missed Pill Effect
NCT03585712Phase 2Completed
- Sponsor
- HRA Pharma
- Start
- Jul 2018
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of norgestrel in contraception (2 arms), sponsored by HRA Pharma. Primary endpoint: Cervical Mucus Score (CMS). Started Jul 2018; status: completed.
02
Drugs
norgestrel
03
Conditions
contraception
Beyond the preview
Go deeper on NCT03585712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03585712.